|
| 35413058 | A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population. | PLoS One | 2022 |
| 27311619 | Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury. | Clin Gastroenterol Hepatol | 2017 |
| 28099038 | An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis. | Am J Respir Crit Care Med | 2017 |
| 28323125 | Minocycline hepatotoxicity: Clinical characterization and identification of HLA-Bâ¿¿35:02 as a risk factor. | J Hepatol | 2017 |
| 28776448 | An exploratory genome-wide analysis of genetic risk for alcoholic hepatitis. | Scand J Gastroenterol | 2017 |
| 28043905 | Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study. | Gastroenterology | 2017 |
| 27349952 | Variant Inosine Triphosphatase Phenotypes Are Associated With Increased Ribavirin Triphosphate Levels. | J Clin Pharmacol | 2017 |
| 26959717 | HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury. | Pharmacogenet Genomics | 2016 |
| 27320325 | Effects of Age, Sex, Body Weight, and Quantity of Alcohol Consumption on Occurrence and Severity of Alcoholic Hepatitis. | Clin Gastroenterol Hepatol | 2016 |
| 27546581 | Reply. | Clin Gastroenterol Hepatol | 2016 |
| 25577150 | Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden. | Virology | 2015 |
| 26531896 | IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearance. | Sci Rep | 2015 |
| 26286715 | Prevalence of genetic variants of keratins 8 and 18 in patients with drug-induced liver injury. | BMC Med | 2015 |
| 25981738 | Clinical application of whole-genome sequencing in patients with primary immunodeficiency. | J Allergy Clin Immunol | 2015 |
| 25645847 | Population pharmacokinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection. | Antimicrob Agents Chemother | 2015 |
| 25735837 | Toward predicting drug-induced liver injury: parallel computational approaches to identify multidrug resistance protein 4 and bile salt export pump inhibitors. | Drug Metab Dispos | 2015 |
| 25446466 | Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice. | Food Chem Toxicol | 2015 |
| 23913866 | Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus. | Hepatology | 2014 |
| 25139357 | A nonsense mutation in IKBKB causes combined immunodeficiency. | Blood | 2014 |
| 24879978 | Genetic basis of drug-induced liver injury: present and future. | Semin Liver Dis | 2014 |
| 24503447 | Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor. | Antivir Ther | 2014 |
| 24452261 | Pharmacogenetics at 50: genomic personalization comes of age. | Sci Transl Med | 2014 |
| 24154606 | Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4. | Drug Metab Dispos | 2014 |
| 23438878 | Whole-genome sequencing in pharmacogenetics. | Pharmacogenomics | 2013 |
| 24304455 | Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy. | J Viral Hepat | 2013 |
| 23935492 | Understanding human variation in infectious disease susceptibility through clinical and cellular GWAS. | PLoS Pathog | 2013 |
| 21703177 | Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients. | J Hepatol | 2012 |
| 23181071 | Impact of the Interaction between 3'-UTR SNPs and microRNA on the Expression of Human Xenobiotic Metabolism Enzyme and Transporter Genes. | Front Genet | 2012 |
| 22968431 | Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs. | Pharmacogenet Genomics | 2012 |
| 22939045 | Prioritizing genetic variants for causality on the basis of preferential linkage disequilibrium. | Am J Hum Genet | 2012 |
| 22511448 | Introduction to the genetics and biology of interleukin-28B. | Hepatology | 2012 |
| 22497812 | Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response. | J Viral Hepat | 2012 |
| 22543885 | The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection. | Dig Dis Sci | 2012 |
| 22594502 | Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here? | Pharmacogenomics | 2012 |
| 22379998 | Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions. | Pharmacogenomics | 2012 |
| 22091778 | Genetic and environmental correlates of topiramate-induced cognitive impairment. | Epilepsia | 2012 |
| 21199653 | Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by adenylosuccinate synthase function. | Gastroenterology | 2011 |
| 22140359 | Copy number variation of KIR genes influences HIV-1 control. | PLoS Biol | 2011 |
| 21570397 | Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. | Gastroenterology | 2011 |
| 21742841 | IL28B genotype effects during early treatment with peginterferon and ribavirin in difficult-to-treat hepatitis C virus infection. | J Infect Dis | 2011 |
| 19855097 | CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance dose. | J Pharmacol Exp Ther | 2010 |
| 20931559 | IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. | Hepatology | 2010 |
| 20547162 | Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction. | Gastroenterology | 2010 |
| 20173735 | ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. | Nature | 2010 |
| 20398883 | Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. | Am J Hum Genet | 2010 |
| 20309922 | Race, ethnicity, ancestry, and pharmacogenetics. | Mt Sinai J Med | 2010 |
| 20399780 | Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus. | Gastroenterology | 2010 |
| 19141711 | Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5). | J Pharmacol Exp Ther | 2009 |
| 20041166 | Common genetic variation and the control of HIV-1 in humans. | PLoS Genet | 2009 |
| 19684573 | Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. | Nature | 2009 |